Evidence map›Paper›PMID 37707622›Full record

ArticleArchives of toxicology2023

Role of ErbB and IL-1 signaling pathways in the dermonecrotic lesion induced by Loxosceles sphingomyelinases D.

Bruna Fernandes Pinto, Priscila Hess Lopes, Carlos Eduardo Madureira Trufen, Ana Tung Ching Ching, Inácio de Loiola Meirelles Junqueira De Azevedo, Milton Yutaka Nishiyama, Paula Cristiane Pohl, Denise V Tambourgi

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Bruna Fernandes Pinto *Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil.
Priscila Hess Lopes *Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil.
Carlos Eduardo Madureira TrufenCzech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
Ana Tung Ching ChingImmunochemistry Laboratory, Butantan Institute, São Paulo, Brazil.
Inácio de Loiola Meirelles Junqueira De AzevedoLaboratoy of Applied Toxinology, Butantan Institute, São Paulo, Brazil.
Milton Yutaka NishiyamaLaboratoy of Applied Toxinology, Butantan Institute, São Paulo, Brazil.
Paula Cristiane PohlImmunochemistry Laboratory, Butantan Institute, São Paulo, Brazil.
Denise V TambourgiImmunochemistry Laboratory, Butantan Institute, São Paulo, Brazil. denise.tambourgi@butantan.gov.br.ORCID http://orcid.org/0000-0003-1896-9074
Instituto Butantan · BRCzech Academy of Sciences, Institute of Molecular Genetics · CZ

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/07467-1
6 · The paper itself

Abstract

Sphingomyelinase D (SMase D), the main toxic component of Loxosceles venom, has a well-documented role on dermonecrotic lesion triggered by envenomation with these species; however, the intracellular mechanisms involved in this event are still poorly known. Through differential transcriptomics of human keratinocytes treated with L. laeta or L. intermedia SMases D, we identified 323 DEGs, common to both treatments, as well as upregulation of molecules involved in the IL-1 and ErbB signaling. Since these pathways are related to inflammation and wound healing, respectively, we investigated the relative expression of some molecules related to these pathways by RT-qPCR and observed different expression profiles over time. Although, after 24 h of treatment, both SMases D induced similar modulation of these pathways in keratinocytes, L. intermedia SMase D induced earlier modulation compared to L. laeta SMase D treatment. Positive expression correlations of the molecules involved in the IL-1 signaling were also observed after SMases D treatment, confirming their inflammatory action. In addition, we detected higher relative expression of the inhibitor of the ErbB signaling pathway, ERRFI1, and positive correlations between this molecule and pro-inflammatory mediators after SMases D treatment. Thus, herein, we describe the cell pathways related to the exacerbation of inflammation and to the failure of the wound healing, highlighting the contribution of the IL-1 signaling pathway and the ERRFI1 for the development of cutaneous loxoscelism.

Indexed as

Sphingomyelin PhosphodiesteraseSpider VenomsAnimalsErbB ReceptorsHumansInflammationInterleukin-1Phosphoric Diester HydrolasesSignal TransductionSpider BitesSpidersErbB ReceptorsInterleukin-1Phosphoric Diester HydrolasesSphingomyelin Phosphodiesterasesphingomyelin phosphodiesterase DSpider VenomsCutaneous loxoscelismDermonecrotic lesionERRFI1IL-1 signalingInflammationSphingomyelinase D

Identifiers

PMID37707622
OpenAlexW4386725885

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.